An observational study in Peri-implantitis, sponsored by Kristianstad University. Enrolling by invitation at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2026-06-29.
Sponsored by Kristianstad University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Peri-Implantitis with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Peri-Implantitis · Sweden.
Among the 21 studies in Peri-Implantitis with a site in Sweden, this one is the only one that started in 2025, is one of 9 observational ones, and was the 20th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →5 of the 21 studies in Peri-Implantitis with a site in Sweden are open now. Recruiting first, the newest first:
Karolinska Institutet · Sites in Sweden
Ages 18+
Koite Health Oy · Sites in Sweden
Ages 18–85
Malmö University · Sites in Sweden, Austria
Ages 18–130
Göteborg University · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 20 is below the median of 84 across 122 observational studies indexed under Peri-Implantitis.
Median enrollment 74 across the 12 interventional studies, 41 across the 9 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 21 have an industry lead sponsor. The 10 most frequent:
Kristianstad University is the lead sponsor of 9 studies on the registry; 2 are open to participants now.
Kristianstad University has 2 studies filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
3 of the studies in Peri-Implantitis with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04847648Göteborg UniversityAir-polishing in the Treatment of Peri-implantitis | 2026-12-15 |
| NCT06648564Kristianstad University20-25 Year Follow-Up on Regenerative Bone Procedures for Peri-Implantitis | 2026-12-31 |
| NCT06017817Koite Health OyAntibacterial Photodynamic Therapy in the Management of Peri-implantitis | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 21 studies in Peri-Implantitis with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this 20-25-year observational study is to investigate the outcomes of bone regenerative surgery in peri-implantitis. Two different techniques will be compared: surgery with a bone substitute alone and surgery with a bone substitute combined with a membrane, to determine their effectiveness and assess whether one is more effective than the other. The intention of this observational study is to learn more about the long-term effects of bone regenerative surgery in patients with peri-implantitis.
Patients will be called in for a clinical and radiographic examination of the surgically treated implant(s). Probing pocket depths, presence of pus, bleeding around the implant (s) and a radiograph of the implant (s).
To be able to compare with the 1, 3, 5 and 10 year measurements.
The aim of this 20-25 year observational follow-up study is to investigate the outcomes of bone regenerative surgery in peri-implantitis. The study compares two approaches: Group 1: surgery with a bone substitute alone (Algipore) and Group 2: surgery with a bone substitute (Algipore) combined with a membrane (Osseoquest). Both groups received systemic antibiotics-Amoxicillin 375 mg three times a day combined with Metronidazole 400 mg twice a day for 10 days, starting the day before surgery.
The objective of this observational study is to gain insights into the long-term effects of bone regenerative surgery in patients with peri-implantitis and to determine if there is a difference.
The patients were enrolled in a strict maintenance program with supportive therapy every third months with a yearly evaluation.
In this study, patients will examined of the surgically treated implant(s) after 20-25 years. The examination will include a clinical assessment, measuring probing pocket depths at each implant to the nearest millimeter using a standardized probing force of 0.25 N (Hawe-Click Probe, Kerr Hawe SA Bioggio, Switzerland). The prevalence of pus, full-mouth bleeding on probing, and bleeding grades will be recorded around the implant(s) at four sites per tooth and implant(s) as follows: 0 = no bleeding, 1 = point of bleeding, 2 = line of bleeding, and 3 = drop of bleeding. The plaque index will be defined as either visible or not visible at the implant site using an erythrosine dye (TopDent Lifco Dental AB, Enköping, Sweden). All clinical assessments will be performed by the same periodontist (AMRJ).
Data from the clinical treatment were registered in patient records. In parallel, clinical data were documented in a study protocol and saved in a safe in accordance with standard operation procedure at the clinic.The protocol with medical records were not opened until the study was completed and only by authorized persons with access to the data in the study such as, principal investigator and statisticians.
In accordance with an international working group diagnosis of peri-implantitis should include pocket depth, bleeding, and bone loss (X-ray). Thus, in this study the primary outcomes are radiographic evidence of bone fill and changes in probing depths at implants treated.
Parametric tests (independent t-tests, equal variance not assumed), and non-parametric tests (Mann-Whitney U-test, Wilcoxon test) will be performed to assess differences over time and between groups. Statistical significance will be declared at p \<0.05. The Kolmogorov- Smirnov test will be used to define if the data presented with normal distribution or not. The SPSS PASW 29.0 statistical software (SPSS Inc., Chicago, IL, USA) for Apple computer will be used in the analysis.
Patients that will participate in the study will consecutively be given an ID code. and data will be registered in the ordinary patient journal. The code list will be placed in a locked up space, at the clinic.
All patients will be given oral and written information about the study and will sign a written informed consent. The patients will be informed that they could drop off when ever they want without any explanations. The ethical board approved the study.
Patients diagnosed with at least one dental implant with peri-implantitis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
Bone regenerativ surgery with a bone graft material (Algipore) and a resorbable membrane (Osseoquest)
Procedure: Bone regenerative surgery with a bone graft substitute and a resorbable membrane
Bone regenerativ surgery with a bone graft material (Algipore)
Dental implants with a diagnosis peri-implantitis were treated with regenerative surgery.
Also known as: Bone regenerative surgery with a bone graft substitute
Bone fill
Radiographic bone fill measured mesial and distal at the implant on an intra oral radiograph. Measurements will be performed by a blinded radiologist.
Time frame: Ten years after surgical regenerative boneprocedures
Probing pocket depths changes
Changes in probing pocket depth at the implant measured on 4 surfaces
Time frame: Ten years after surgical regenerative boneprocedures
Bleeding
Bleeding on probing measured at the implant on 4 sites.
Time frame: Ten years after surgical regenerative boneprocedures
Graded bleeding
Graded bleeding measured at the implant on 4 sites as: 0 = no bleeding, 1 = point of bleeding, 2 = line of bleeding, and 3 = drop of bleeding.
Time frame: Ten years after surgical regenerative boneprocedures
Plan to share: Undecided — May be shared upon request
Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.
Of 33 non-industry observational studies under Peri-Implantitis, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 77. This study's planned 16 months is close to that.
Counting every sponsor, half of 35 studies reached it within 17 months; a quarter within 8 and three quarters within 77.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kristianstad University